27 related articles for article (PubMed ID: 20189473)
1. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
[TBL] [Abstract][Full Text] [Related]
2. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression.
Lionetti R; Tisone G; Palmieri G; Almerighi C; Anselmo A; Tariciotti L; Lenci I; De Luca L; Monaco A; Angelico M
Dig Liver Dis; 2010 Apr; 42(4):297-303. PubMed ID: 19818696
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
[TBL] [Abstract][Full Text] [Related]
5. [What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].
Malfertheiner P
Dtsch Med Wochenschr; 2002 Nov; 127(48):2580. PubMed ID: 12457331
[No Abstract] [Full Text] [Related]
6. Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C.
Trepo C; Bailly F
Dig Liver Dis; 2010 Apr; 42(4):283-4. PubMed ID: 20189473
[No Abstract] [Full Text] [Related]
7. Management of recurrent hepatitis C after liver transplantation: a concise review.
Szabo G; Katz E; Bonkovsky HL
Am J Gastroenterol; 2000 Sep; 95(9):2164-70. PubMed ID: 11007212
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?
Bizollon T; Trepo C
J Hepatol; 2002 Aug; 37(2):274-6. PubMed ID: 12127435
[No Abstract] [Full Text] [Related]
9. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
Iino S
Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent hepatitis C after liver transplantation.
Biggins SW; Terrault NA
Clin Liver Dis; 2005 Aug; 9(3):505-23, ix. PubMed ID: 16023980
[TBL] [Abstract][Full Text] [Related]
11. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
Zeuzem S
Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
[No Abstract] [Full Text] [Related]
12. How should we treat recurrent hepatitis C after liver transplantation?
Morard I; Negro F
J Hepatol; 2005 Apr; 42(4):462-8. PubMed ID: 15763327
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
